Latest News & Features
Generics
New Jersey pharma company Jacobus Pharmaceutical has asked the US Supreme Court to review an 11th Circuit verdict that it claims “eviscerated” decades of precedent regarding Orphan Drug Act exclusivity. 14 April 2022
Americas
GlaxoSmithKline has agreed to acquire California-based biopharma company Sierra Oncology for $1.9 billion, in a move that bolsters the UK company’s cancer business. 14 April 2022
Medtech
A Texas jury has handed a $12 million victory to an Israeli company after finding that Danish company 3Shape’s dental scanner infringed one of its patents. 12 April 2022
Medtech
Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent. 12 April 2022
Big Pharma
The US Patent Trial and Appeal Board has agreed to review claims of a Seagen patent that Daiichi Sankyo was found to have infringed with its Enhertu breast cancer treatment. 11 April 2022
Generics
Bristol Myers Squibb has sued MSN Laboratories over its planned generic of Pomalyst, which it claims infringes six patents owned by BMS’ subsidiary Celgene. 7 April 2022
Big Pharma
Qiagen has asked a Delaware court to issue a declaratory judgment that its method for testing for COVID-19 in wastewater does not infringe Bio-Rad’s patents. 7 April 2022
article
A new referral to the European Patent Office’s enlarged board of appeal will determine whether post-filed data can be used to support inventive steps in patentability, as Sarah Gibbs of Appleyard Lees reports. 7 April 2022
Europe
Patent applications in Europe reached record levels during 2021 amid the COVID-19 pandemic, according to a new report by the European Patent Office. 5 April 2022
Generics
Merck Sharp & Dohme has filed a complaint against New Dehli-based Mankind Pharma, looking to halt the approval of a generic version of the type two diabetes treatment, Januvia. 5 April 2022